PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,329,827 | -52.2% | 319,534 | -20.8% | 0.13% | -50.0% |
| Q2 2023 | $11,148,758 | +46.3% | 403,648 | +21.8% | 0.26% | +16.1% |
| Q1 2023 | $7,619,486 | +99.5% | 331,282 | -5.4% | 0.22% | +107.4% |
| Q4 2022 | $3,819,951 | +357.5% | 350,133 | +253.4% | 0.11% | +332.0% |
| Q3 2022 | $835,000 | +6.5% | 99,087 | -0.1% | 0.02% | +13.6% |
| Q2 2022 | $784,000 | -66.0% | 99,176 | +2.0% | 0.02% | -59.3% |
| Q1 2022 | $2,303,000 | -36.1% | 97,265 | -7.7% | 0.05% | -28.9% |
| Q4 2021 | $3,604,000 | +81.2% | 105,394 | -6.1% | 0.08% | +68.9% |
| Q3 2021 | $1,989,000 | -38.4% | 112,265 | +56.0% | 0.04% | -34.8% |
| Q2 2021 | $3,229,000 | +65.1% | 71,947 | -4.7% | 0.07% | +76.9% |
| Q1 2021 | $1,956,000 | – | 75,518 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |